H. Lee Moffitt Cancer Center & Research Institute, Inc. is a clinical research site located in Tampa, Florida, United States 33612.
Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.
H. Lee Moffitt Cancer Center & Research Institute, Inc. has participated in 14 clinical trials with 2 currently active.
Therapeutic areas: Leukemia, Myelomonocytic, Chronic, Relapsed or Refractory Peripheral T-Cell Lymphoma, Solid Tumors Harboring a BRAF V600 Mutation.
Sponsors: Kura Oncology, Inc., Pfizer, Senhwa Biosciences, Inc..
Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
H. Lee Moffitt Cancer Center & Research Institute, Inc. has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
H. Lee Moffitt Cancer Center & Research Institute, Inc. has 14 clinical trials on record, with 2 currently active. Their work covers Leukemia, Myelomonocytic, Chronic, Relapsed or Refractory Peripheral T-Cell Lymphoma, Solid Tumors Harboring a BRAF V600 Mutation.
Yes — H. Lee Moffitt Cancer Center & Research Institute, Inc. holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.